None
Describe characteristics of adolescents with autism spectrum disorder (ASD).
Identify common co-occurring conditions.
Describe strategies for working with teens who have ASD.
Spectrum Disorder: Developmental disability affecting communication, learning, behavior, and social interaction.
Difficulty with communication and social interaction.
Restricted interests and repetitive behaviors.
Different learning, movement, and attention mechanisms.
Obsessive interests.
Self-stimulating behaviors (stimming) such as hand flapping or rocking.
Delayed skills in language, movement, and cognition.
Sleep and eating habit issues.
Level 1: Requires support
Marked deficits in social communication.
Inflexibility and difficulty coping with change.
Level 2: Requires substantial support
Severe deficits in verbal and nonverbal communication.
Extreme difficulty coping with change affecting functionality.
Level 3: Requires very substantial support
Severe deficits in communication; may necessitate multiple medications and transitioning planning.
Provide organizational support at school and home.
Accommodations in test-taking and homework.
Discuss social media with parents and teens.
Facilitate social skill groups and connections with peers.
Higher organizational aid and potential IEP features like special education classes.
Continuation of therapy (speech, occupational).
Social media monitoring discussion with parents.
Employment transition planning within IEPs.
More comprehensive IEP involvement; may involve special education settings.
Continuous speech and occupational therapy.
Planning for adult living support and possible guardianship.
SSRIs: Effective for anxiety and associated symptoms (e.g., perseveration, irritability).
Psychostimulants: Helpful for inattention, impulsivity.
Alpha-2 Agonists (Clonidine, Guanfacine): Aid sleep issues but should be monitored closely.
Refer to psychiatry for unresponsive cases.
No disclosures.
Describe cognitive differences in teens coping with grief.
Recognize and differentiate prolonged grief disorder (PGD) from typical bereavement using evidenced-based tools.
Discuss strategies for facilitating grief support.
Unique emotional responses that significantly impact individuals.
Important role of Nurse Practitioners in grief support for teens.
Estimated 6.3 million children in the U.S. experience parental bereavement by age 18.
Approximately 10% of bereaved individuals may suffer from PGD.
Understanding death's universality and finality through abstract thinking.
Physical, emotional, behavioral, and cognitive responses to grief.
Complicated grief in surviving parents can influence teens' grief experiences.
Practical strategies include communication, psych-education, anticipatory guidance, and collaborative approaches using referral to behavioral therapies as needed.
PHQ-9 Modified for Teens: High sensitivity and specificity for detecting depression.
Adolescent Grief Inventory: Valid measure for adolescent grief assessment.
Inventory of Complicated Grief (ICG-RC): Assists in identifying complicated grief in bereaved youth.
Doxycycline is a broad-spectrum antibiotic effective against certain STIs (e.g., Chlamydia).
DoxyPEP can prevent STIs if administered within 72 hours post-exposure.
Dosage: 200 mg orally once; repeat once a day based on sexual frequency.
Use in populations such as Transgender Women (TGW) and Men who have Sex with Men (MSM).
Essential discussions for patients to enhance awareness of benefits and risks.
Transition patients from pediatric to adult care should begin discussions around 13-14 years.
Only 17% of patients with ID/DD received full HCT guidance.
Resources discussed include Got Transition® and assessments for readiness.
Query state requirements for adult services, including parental support roles post-18 and guardianship issues.
Importance of thorough legal counsel on estate planning and implications for adulthood.
Opill became available OTC in 2023 after years of research.
Safety and effectiveness were established for consumer use without supervision.
Opill works by suppressing ovulation and thickening cervical mucus.
Efficacy rates: 98% perfect use, 93% typical use.
Caused by Neisseria meningitidis; severe outcomes can include long-term disabilities.
Specific vaccine recommendations for adolescents from age 11-12 and boosters at age 16.
Quadrivalent vaccine covers serotypes A, C, W & Y; recommended for adolescents and those at risk.
New Pentavalent vaccine approved for broader protection against these serotypes.